<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03929341</url>
  </required_header>
  <id_info>
    <org_study_id>2014-0069-B</org_study_id>
    <nct_id>NCT03929341</nct_id>
  </id_info>
  <brief_title>Risk Evaluation and Stratification of Low Risk for Cardiovascular Disease in Women</brief_title>
  <acronym>RESOLVE</acronym>
  <official_title>Risk Evaluation and Stratification of Low Risk for Cardiovascular Disease in Women: An Innovative Strategy for Investigating Stable Chest Pain in Low to Intermediate Risk Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Elsie Nguyen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Women's College Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the ability of Coronary Computed Tomography Angiography (CCTA), used&#xD;
      as a first-line diagnostic tool in women with stable chest pain and low risk for Coronary&#xD;
      Artery Disease (CAD), to reduce the number of women requiring more than one diagnostic test&#xD;
      to rule in or rule out CAD. Half of the participants will undergo CCTA as the first test to&#xD;
      investigate stable chest pain, while the other half will undergo any test ordered by their&#xD;
      family physician.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Coronary artery disease (CAD) is the leading cause of death in women globally. Women are more&#xD;
      likely to present with atypical chest pain that may be difficult to diagnose using&#xD;
      traditional testing methods, resulting in over-investigation.&#xD;
&#xD;
      Coronary computed tomography angiography (CCTA) has high negative predictive value for&#xD;
      exclusion of CAD in low to intermediate risk populations. We plan to investigate CCTA as a&#xD;
      first line test to exclude coronary artery disease as a cause of stable chest pain and&#xD;
      whether it is a cost effective strategy that reduces time to diagnosis, wait times to see&#xD;
      cardiologists, emergency department visits, downstream and repeat testing and radiation&#xD;
      exposure as compared to usual care with comparable patient safety and satisfaction level.&#xD;
&#xD;
      Another intervention being tested in this trial is the Cardiac Link pathway. This is a new&#xD;
      clinical program at Women's College Hospital that aims to expedite cardiology referral for&#xD;
      patients exhibiting clinically significant findings while undergoing CCTAs.&#xD;
&#xD;
      We hope that with use of CCTA as the first test, the number of women who require only one&#xD;
      test (i.e. CCTA) to sort out whether or not CAD is responsible for their chest pain will&#xD;
      increase, thereby decreasing over-investigation of low risk women.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">January 24, 2019</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Number of Tests</measure>
    <time_frame>Through study completion, which may take up to 1 year</time_frame>
    <description>The total number of tests a patient has to complete in order to diagnose the cause of their chest pain or equivalent symptoms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Diagnosis</measure>
    <time_frame>From date of first presentation with chest pain to date of CAD diagnosis or exclusion, assessed up to 24 months</time_frame>
    <description>Time interval from time of presentation to family physician for evaluation of chest pain to the last test performed to determine etiology of chest pain or CAD exclusion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wait Times to See a Cardiologist</measure>
    <time_frame>From date of cardiology referral letter sent by family physician to date of cardiologist appointment with patient, assessed up to 24 months</time_frame>
    <description>Time interval from when family physician referral letter was sent to the cardiologist's office to appointment time to see cardiologist</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital/ER visits</measure>
    <time_frame>Through study completion, which may take up to 1 year</time_frame>
    <description>Number of hospital/ER visits while waiting to see cardiologist</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Normal Invasive Diagnostic Angiograms</measure>
    <time_frame>From date of randomization to date of CAD diagnosis or exclusion, assessed up to 24 months</time_frame>
    <description>Number of invasive diagnostic angiograms done that reveal no coronary artery disease.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Cost of Investigations</measure>
    <time_frame>Through study completion, which may take up to 1 year</time_frame>
    <description>Total cost (in Canadian dollars) of all tests completed to reach a diagnosis for chest pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative Radiation Dose Exposure (milliSieverts)</measure>
    <time_frame>From date of randomization to date of CAD diagnosis or exclusion, assessed up to 24 months</time_frame>
    <description>Total effective radiation dose from all testing modalities for each patient.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence of Procedure Related Adverse Events</measure>
    <time_frame>From date of randomization to date of CAD diagnosis or exclusion, assessed up to 24 months</time_frame>
    <description>Assessment of diagnostic procedure related adverse effects that may occur during the course of the trial.</description>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of Cardiovascular Events</measure>
    <time_frame>From date of randomization to date of CAD diagnosis or exclusion, assessed up to 24 months</time_frame>
    <description>Assessment of cardiovascular events that may take place during the course of the study, while waiting for a diagnosis for the cause of chest pain</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Chest Pain</condition>
  <arm_group>
    <arm_group_label>CCTA first approach with Cardiac Link</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient will undergo Coronary Computed Tomography Angiography as the first test and have Cardiac Link pathway activated for expedited cardiology referral.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CCTA first approach without Cardiac Link</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient will undergo Coronary Computed Tomography Angiography as the first test, but Cardiac Link pathway will not be activated.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care with Cardiac Link</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient will undergo the usual diagnostic test ordered by their family physician as the first test, and have Cardiac Link pathway activated for expedited cardiology referral.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care without Cardiac Link</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient will undergo the usual diagnostic test ordered by their family physician as the first test, but Cardiac Link pathway will not be activated.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Coronary Computed Tomography Angiography (CCTA)</intervention_name>
    <description>Cardiac imaging test that is able to detect changes is cardiac vessels and the heart.</description>
    <arm_group_label>CCTA first approach with Cardiac Link</arm_group_label>
    <arm_group_label>CCTA first approach without Cardiac Link</arm_group_label>
    <arm_group_label>Usual Care with Cardiac Link</arm_group_label>
    <arm_group_label>Usual Care without Cardiac Link</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiac Link</intervention_name>
    <description>Clinical patient flow pathway that will enable radiologist to activate expedited cardiology referral for patients who exhibit clinically significant changes during CCTA.</description>
    <arm_group_label>CCTA first approach with Cardiac Link</arm_group_label>
    <arm_group_label>Usual Care with Cardiac Link</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men and women age â‰¥ 40 years of age&#xD;
&#xD;
          -  Stable chest pain or equivalent symptoms&#xD;
&#xD;
          -  Planned non-urgent, non-invasive testing for diagnosis of chest pain or equivalent&#xD;
             symptoms&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute coronary syndrome, including acute myocardial infarction or unstable angina,&#xD;
             known non-ischemic cardiomyopathy or other cardiac disease (e.g. mitral valve&#xD;
             prolapse, etc.) which would require urgent cardiac evaluation&#xD;
&#xD;
          -  Known CAD&#xD;
&#xD;
          -  Prior cardiac evaluation for current episode of symptoms&#xD;
&#xD;
          -  Previously investigated for CAD in the last 12 months&#xD;
&#xD;
          -  Severe allergic reaction to iodinated contrast (mild reactions such as urticaria that&#xD;
             can be controlled by premedication with Benadryl &amp; Prednisone may be included in the&#xD;
             study)&#xD;
&#xD;
          -  Renal failure or dysfunction (estimated Glomerular Filtration Rate&lt;30ml/min/m2 within&#xD;
             the past 3 months)&#xD;
&#xD;
          -  Pregnancy (status will be confirmed verbally. For premenopausal patients who are&#xD;
             unsure, status will be confirmed by completing a pregnancy strip test).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elsie T Nguyen, MD, FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Women's College Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fahmeen J Afgani, MBBS</last_name>
    <phone>1-416-323-6400</phone>
    <phone_ext>7319</phone_ext>
    <email>fahmeen.afgani@wchospital.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elsie T Nguyen, MD, FRCPC</last_name>
    <phone>1-416-340-4800</phone>
    <phone_ext>3291</phone_ext>
    <email>elsie.nguyen@uhn.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Women's College Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5S1B2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fahmeen J Afgani, MBBS</last_name>
      <phone>416-323-6400</phone>
      <phone_ext>7319</phone_ext>
      <email>fahmeen.afgani@wchospital.ca</email>
    </contact>
    <investigator>
      <last_name>Paula J Harvey, BMBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Deborah Levitan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>January 15, 2019</study_first_submitted>
  <study_first_submitted_qc>April 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2019</study_first_posted>
  <last_update_submitted>April 26, 2019</last_update_submitted>
  <last_update_submitted_qc>April 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Women's College Hospital</investigator_affiliation>
    <investigator_full_name>Elsie Nguyen</investigator_full_name>
    <investigator_title>Associate Professor of Radiology</investigator_title>
  </responsible_party>
  <keyword>angina</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Chest Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

